130 related articles for article (PubMed ID: 17611158)
1. T cell immunomodulation--the Holy Grail of therapeutic tolerance.
Isaacs JD
Curr Opin Pharmacol; 2007 Aug; 7(4):418-25. PubMed ID: 17611158
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
Bach JF
C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496
[TBL] [Abstract][Full Text] [Related]
3. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications.
Chatenoud L
Curr Opin Immunol; 2005 Dec; 17(6):632-7. PubMed ID: 16214320
[TBL] [Abstract][Full Text] [Related]
4. The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.
Chatenoud L
Handb Exp Pharmacol; 2008; (181):221-36. PubMed ID: 18071948
[TBL] [Abstract][Full Text] [Related]
5. Use of CD3 antibodies in transplantation and autoimmune diseases.
Chatenoud L
Transplant Proc; 1994 Dec; 26(6):3191-3. PubMed ID: 7998111
[No Abstract] [Full Text] [Related]
6. Anti-CD3 antibodies: towards clinical antigen-specific immunomodulation.
Chatenoud L
Curr Opin Pharmacol; 2004 Aug; 4(4):403-7. PubMed ID: 15251136
[TBL] [Abstract][Full Text] [Related]
7. CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic.
Chatenoud L
Int Rev Immunol; 2006; 25(3-4):215-33. PubMed ID: 16818372
[TBL] [Abstract][Full Text] [Related]
8. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies for the therapeutic induction of tolerance.
Waldmann H; Qin S; Cobbold SP
Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
[No Abstract] [Full Text] [Related]
10. The Immune Tolerance Network: tolerance at the crossroads.
Bluestone JA; Matthews J
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):773-6. PubMed ID: 11375080
[TBL] [Abstract][Full Text] [Related]
11. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
[TBL] [Abstract][Full Text] [Related]
12. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
[TBL] [Abstract][Full Text] [Related]
13. CD3-specific antibodies: a portal to the treatment of autoimmunity.
Chatenoud L; Bluestone JA
Nat Rev Immunol; 2007 Aug; 7(8):622-32. PubMed ID: 17641665
[TBL] [Abstract][Full Text] [Related]
14. Immunology. Policing the immune system.
Wickelgren I
Science; 2004 Oct; 306(5696):596-9. PubMed ID: 15498987
[No Abstract] [Full Text] [Related]
15. From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation.
Reisner Y; Martelli MF
Blood Cells Mol Dis; 2008; 40(1):1-7. PubMed ID: 17981059
[TBL] [Abstract][Full Text] [Related]
16. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
[TBL] [Abstract][Full Text] [Related]
17. Drug insight: New immunomodulatory therapies in type 1 diabetes.
Cernea S; Herold KC
Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):89-98. PubMed ID: 16932263
[TBL] [Abstract][Full Text] [Related]
18. TRX-4 (TolerRx Inc).
Brown WM
IDrugs; 2006 Apr; 9(4):283-91. PubMed ID: 16596483
[TBL] [Abstract][Full Text] [Related]
19. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
[TBL] [Abstract][Full Text] [Related]
20. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
